MIMIX Trademark

Trademark Overview


On Tuesday, September 15, 2020, a trademark application was filed for MIMIX with the United States Patent and Trademark Office. The USPTO has given the MIMIX trademark a serial number of 90182815. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2024. This trademark is owned by Vaxess Technologies, Inc.. The MIMIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with pain relief medication; drug delivery a...
mimix

General Information


Serial Number90182815
Word MarkMIMIX
Filing DateTuesday, September 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with pain relief medication; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with hormones for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVaxess Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameVaxess Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, September 18, 2020NEW APPLICATION ENTERED
Thursday, October 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021ASSIGNED TO LIE
Thursday, January 28, 2021ASSIGNED TO LIE
Wednesday, January 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 26, 2021SOU EXTENSION 1 FILED
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 26, 2021SOU TEAS EXTENSION RECEIVED
Monday, July 26, 2021SOU EXTENSION 1 GRANTED
Wednesday, July 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 25, 2022SOU EXTENSION 2 FILED
Friday, February 25, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 25, 2022SOU EXTENSION 2 GRANTED
Wednesday, August 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 13, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 29, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 29, 2022SOU EXTENSION 3 FILED
Monday, August 29, 2022SOU EXTENSION 3 GRANTED
Monday, February 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 13, 2023SOU EXTENSION 4 FILED
Wednesday, February 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, October 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 11, 2023SOU EXTENSION 5 FILED
Thursday, October 26, 2023SOU EXTENSION 5 GRANTED